The M&A practice at Goodwin encompasses the full range of M&A and private equity work, relied upon by a host of private and publicly-listed corporations, PE funds and financial advisors. The team is particularly proficient in handling buy-side matters in the life sciences, healthcare, and technology sectors. Co-head Joshua Zachariah, based in New York, is highly regarded for his transactional expertise in the healthcare and technology sectors. Meanwhile, co-head Lawrence Chu has built a strong track record advising technology clients out of the firm’s Silicon Valley office. Michael Kendall, who co-heads the team from the Boston office, focuses on advising an array of private equity and venture capital funds on leveraged buyouts and early and late-stage investments.
Legal 500 Editorial commentary

Accolades

Client satisfaction: Lawyer & team quality

Key clients

  • Ansys
  • Anthos
  • Avadel Pharmaceuticals
  • Beekeeper
  • BlueHalo
  • Blueprint Medicines
  • Enfusion
  • Harness
  • IDRx, Inc.
  • Federici Brands LLC
  • Melio Payments Inc.
  • MeridianLink, Inc.
Practice head

Michael Kendall; Lawrence Chu; Joshua Zachariah